These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 510117)

  • 1. Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus.
    Steyn LV; Drew D; Vlachos D; Huey B; Cocchi K; Price ND; Johnson R; Putnam CW; Papas KK
    PLoS One; 2023; 18(6):e0278794. PubMed ID: 37384782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985.
    Pfeiffer EF
    Diabetologia; 1987 Feb; 30(2):51-65. PubMed ID: 3552826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)].
    Buysschaert M; Lambotte L; Lambert AE
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of guar gum on 24-hour insulin requirements of insulin-dependent diabetic subjects as assessed by an artificial pancreas.
    Christiansen JS; Bonnevie-Nielsen V; Svendsen PA; Rubin P; Rønn B; Nerup J
    Diabetes Care; 1980; 3(6):659-62. PubMed ID: 7004812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children.
    Mimouni M; Koivukangas T; Karp M; Laron Z
    Acta Diabetol Lat; 1979; 16(1):63-6. PubMed ID: 377878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an artificial pancreas as a tool to determine subcutaneous insulin doses in juvenile diabetes.
    Lambert AE; Buysschaert M; Lambotte L
    Diabetes Care; 1979; 2(3):256-64. PubMed ID: 510117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.